Are there any emerging therapies targeting blood flow in cancer?
Emerging therapies are increasingly focusing on targeting blood flow to improve cancer treatment. One such approach is the use of vascular disrupting agents (VDAs), which aim to destroy existing tumor blood vessels. Another promising area is the development of nanoparticle-based drug delivery systems, designed to enhance the penetration and retention of drugs within the tumor by exploiting the unique properties of the tumor vasculature.
